Canada Insulin Delivery Devices Market

Insulin, a glucose directing hormone, is an essential part of the treatment plan for people with type 1 diabetes mellitus and advanced type 2 diabetes mellitus. Insulin helps control the body's blood sugar level. Insulin helps the body to use sugar for the energy it needs, and then store the rest. Insulin keep blood sugar level in a normal range as much as possible. Type or dosage of insulin can be changed, to meet the individual needs of the patient. There are different ways to inject insulin into the body, such as vials and syringes, insulin pens, and insulin pumps, this is called insulin delivery. Market Dynamics Increasing prevalence of diabetes, increasing awareness among people, and increasing demand for advanced insulin delivery devices are some major factors expected to propel growth of the Canada insulin delivery devices market during the forecast period. For instance, according to Diabetes Canada (March 2022), today, more than 5.7 million Canadians living with diagnosed diabetes (type 1 or type 2 diabetes). Furthermore, the Public Health Agency of Canada (PHAC), in collaboration with all provinces and territories, conducts national surveillance of diabetes to support planning and evaluation of related policies and programs. Key features of the study • This report provides in-depth analysis of the Canada insulin delivery devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year. • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players. • It profiles key players in the Canada insulin delivery devices market based on the following parameters, such as company highlights, products portfolio, key highlights, financial performance, and strategies. • Key companies covered as a part of this study include Medtronic, Novo Nordisk, Eli Lilly, Sanofi, Ypsomed Holding AG, Tandem, Insulet Corporation, F. Hoffmann-La Roche Ltd., and Becton Dickinson and Company, among others. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics. • The Canada insulin delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Canada insulin delivery devices market. Market Segmentation • By Insulin Delivery Devices Insights (Revenue, US$ Mn, 2020 - 2033) o Insulin Pump o Insulin Syringes o Insulin Disposable Pens o Insulin Cartridges in Reusable Pens o Insulin Jet Injectors • Key Players o Medtronic o Novo Nordisk o Eli Lilly o Sanofi o Ypsomed Holding AG o Tandem o Insulet Corporation o Hoffmann-La Roche Ltd. o Becton Dickinson and Company